Two new classifications for myeloid neoplasms were introduced in 2022: the International Consensus Classification (ICC) and the 5th edition WHO Classification (WHO-HAEM5). Both classifications build ...

As AML classification has shifted toward identifying genetically distinct subtypes, targeted therapies have been incorporated during induction treatment, which is ideally started within 5 days of ...

Acute monocytic leukemia is a distinct subtype of acute myeloid leukemia (AML) with characteristic biologic and clinical features. This study was designed to compare the outcome of patients with M5 to ...